Dr. Suling Liu is currently a professor at Fudan University Cancer Hospital and Institutes of Biomedical Sciences. Dr. Liu's research has focused on characterization and regulation mechanisms of normal and malignant breast stem cells. Evidence from this research is of obvious significance for the development of new diagnosis tools and innovative treatments for breast cancer. After getting PhD from Ohio State University, her research interest on breast carcinogenesis took her to focus on cancer therapy to find novel treatments to cancer by targeting the cancer stem cells. In the past, she has been studying breast cancer stem cell heterogeneity and the interplay with tumor microenvironment. In recent five years, as a corresponding or co-corresponding author, Dr. Liu has published 29 research articles in Nature Cell Biology, Advanced Science, Nature Communications, Science Advances, Cancer Research, Clinical Cancer Res, Plos Biology and other famous SCI Journals (total over 91 publications which has been cited over 18000 times).